Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1240 of 6351
-
Could an antidepressant ease chronic bladder pain? new trial investigates
Symptom relief Not yet recruitingThis study aims to compare two treatment plans for adults with bladder pain syndrome (also called interstitial cystitis), a disease that causes long-lasting bladder pain, frequent urination and urgent need to pee. All participants will receive standardized patient education and b…
Phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Fetal stem cells aim to tame immune chaos
Disease control Not yet recruitingThe primary objectives are to evaluate the safety and efficacy of infusion of the third party fully-characterized clonally derived fetal MSCs (cfMSCs) for the control of severe symptoms associated with acute and chronic immune-related disorders and tissue damage.
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Ice vs spray: which stops chemo mouth pain?
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the effectiveness of oral cryotherapy compared with topical lidocaine spray in preventing and reducing the severity of chemotherapy-induced oral mucositis among adult patients with cancer receiving chemotherapy. It will also assess t…
Sponsor: Hanady Jabbar Mahmood • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can cholesterol drugs shield the heart during melanoma immunotherapy?
Disease control Recruiting nowImmune checkpoint inhibitors (ICIs) are a class of medications that are now standard in the treatment of melanoma. These are standard therapy for melanoma, but long-term side effects on disease in the heart arteries is poorly understood. In this study, melanoma patients receiving…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Genetically modified cells injected into mouth lesions to stop cancer before it starts
Disease control Not yet recruitingThis is a phase 1, single-arm, open-label, dose-escalation and dose-expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of TGFBR2 TROP2 CAR/IL15 NK cells in patients with high-risk oral premalignant lesions.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Off-the-Shelf CAR t cells take on tough blood cancers
Disease control Not yet recruitingThe purpose of this study is to assess the feasibility, safety and efficacy of universal CAR T cell therapy against CD19-positive hematological malignancies using a novel CD19-specific CAR T cell product, 4SCAR19U T cells. The study also aims to learn more about the function of t…
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New PET scan could replace biopsies for breast cancer patients
Diagnosis Not yet recruitingOASIS-ImmunoPET is a monocentric pilot study evaluating antibody imaging to predict response to antibody-drug conjugate (ADC), an innovative cancer targeted therapy, and potentially replace tumor biopsy. It is addressed to patients with locally advanced or metastatic breast cance…
Phase 2 • Sponsor: UNICANCER • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
A global effort to make moving critically ill patients safer
Knowledge-focused Not yet recruitingThe HERMES Phase III study is an international, multicenter, prospective observational investigation designed to characterize the quality and safety of patient transport during advanced respiratory support. The study will enroll patients undergoing prehospital, interhospital, or…
Sponsor: Medipol University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Could a single injection reprogram immune cells to tame lupus and scleroderma?
Disease control Not yet recruitingThis is an open-label, single-arm study designed to evaluate the safety and preliminary efficacy of HN2302 in patients with autoimmune diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).
Phase 1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can stem cells save dying hip bones? new study halted
Disease control PausedThe purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
Phase 1/2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can light boost PRP's power against hair loss?
Disease control Not yet recruitingThe goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer: Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue …
Early phase 1 • Sponsor: Kimberly Meathrel • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Head-to-Head: which drug combo tames psoriatic arthritis better?
Disease control Not yet recruitingThe aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate
Sponsor: Tanta University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Smart alerts aim to slash stroke risk in heart patients
Prevention Not yet recruitingAtrial fibrillation (AF) is the most preventable cause of stroke. However, despite widely available risk stratification tools, numerous options for oral anticoagulation, and evidence-based practice guidelines, anticoagulation for stroke prevention in AF is consistently under-pres…
Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New shoulder implant aims to cut Re-Tear rates after rotator cuff surgery
Disease control PausedThe study design is a prospective, multi-center, single-arm, non-randomized, and noncontrolled post market clinical follow-up study involving orthopedic surgeons skilled in arthroscopic rotator cuff repair as determined by the Sponsor.
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Freeze away stomach bleeding: new spray trial offers hope
Disease control Recruiting nowThe purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous …
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug aims to keep leukemia in remission after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of asciminib as maintenance treatment for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) who have undergone cellular therapies such as hematopoietic stem cell transplantation (HSCT) o…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo targets hard-to-treat lymphoma
Disease control Not yet recruitingThis phase II trial tests the effect of nemtabrutinib in combination with rituximab in treating patients with marginal zone lymphoma. Nemtabrutinib, a non-covalent Bruton's tyrosine kinase (BTK) inhibitor, may stop the growth of cancer cells by blocking some of the enzymes needed…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New blood test score could personalize heart failure diuretic use
Disease control Not yet recruitingBy the re-analysis, in the BIOTOOL-CHF DISCO study, of a previously enrolled cohort of patients, a Biological Congestion Score (BCS) was newly developed. The BCS integrates four congestion-related biomarkers with key clinical variables. The BIOTOOL-CHF VALID trial is designed to …
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a blood injection ease Amputees' nerve pain?
Symptom relief Not yet recruitingPatients with combat-related amputations frequently experience chronic neuroma pain that may interfere with rehabilitation, prosthesis use, mobility, sleep, and quality of life. Current treatment approaches often provide only temporary pain relief. Platelet-rich plasma (PRP) has…
Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug aims to stop Post-Surgery breathing danger
Prevention Not yet recruitingThis study is a Phase II, randomized, placebo-controlled, double-blind trial in 200 subjects having general anesthesia for major elective surgery with postoperative pain management to evaluate the efficacy, safety and tolerability of ENA-001 as a therapy to prevent post operative…
Phase 2 • Sponsor: Enalare Therapeutics Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC